☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Day One
Day One Entered into an Exclusive License Agreement and Research Collaboration with Sprint Bioscience for VRK1 Program
August 17, 2023
Merck KGaA Signs an Exclusive Worldwide License Agreement with Day One for Pimasertib and MSC2015103B
February 24, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.
